Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

CJD Ross, H Katzov-Eckert, MP Dubé, B Brooks… - Nature …, 2009 - nature.com
Cisplatin is a widely used and effective chemotherapeutic agent, although its use is restricted
by the high incidence of irreversible ototoxicity associated with it 1 . In children, cisplatin …

Introducing pharmacogenetic testing with clinical decision support into primary care: a feasibility study

…, A Suarez-Gonzalez, H Katzov-Eckert - … Open Access Journal, 2016 - cmajopen.ca
Background: Inappropriate prescribing increases patient illness and death owing to adverse
drug events. The inclusion of genetic information into primary care medication practices is …

[HTML][HTML] A two-dimensional pooling strategy for rare variant detection on next-generation sequencing platforms

…, RE Denroche, G Fehringer, H Katzov-Eckert… - PloS one, 2014 - journals.plos.org
We describe a method for pooling and sequencing DNA from a large number of individual
samples while preserving information regarding sample identity. DNA from 576 individuals …

[HTML][HTML] Phylodynamics and dispersal of HRSV entails its permanence in the general population in between yearly outbreaks in children

H Katzov-Eckert, VF Botosso, EA Neto, PMA Zanotto… - 2012 - journals.plos.org
Background Human respiratory syncytial virus (HRSV) is one of the major etiologic agents of
respiratory tract infections among children worldwide. Methodology/Principal Findings Here …

[HTML][HTML] Evaluation of buccal swabs for pharmacogenetics

…, A Suarez-Gonzalez, M Dawes, H Katzov-Eckert - BMC Research …, 2018 - Springer
Objective A simple, non-invasive sample collection method is key for the integration of
pharmacogenetics into clinical practice. The aim of this study was to gain samples for …

[HTML][HTML] Improving prescribing: a feasibility study of pharmacogenetic testing with clinical decision support in primary healthcare in Singapore

H Smith, M Dawes, H Katzov-Eckert, S Burrell… - Family …, 2022 - academic.oup.com
Background The study of genetic variation as a factor influencing drug safety, efficacy, and
effectiveness has brought about significant breakthroughs in understanding the clinical …

Pharmacogenetic Algorithms

B Esquivel, C Verzosa, H Katzov-Eckert… - … in Clinical Practice, 2024 - Springer
Pharmacogenetic Pharmacogenetics clinical algorithms Clinical Algorithms represented by
logistic steps in the decision-making process are designed to shift pharmacogenetics from …

Identification of a novel MSH6 germline variant in a family with multiple gastro-intestinal malignancies by next generation sequencing

AA Connor, H Katzov-Eckert, T Whelan, M Aronson… - Familial Cancer, 2015 - Springer
The identification of germline variants that predispose to cancer is important to further our
understanding of tumorigenesis, guide patient management, prevent disease in unaffected …

Erratum: Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

CJD Ross, H Katzov-Eckert, MP Dubé, B Brooks… - Nature Genetics, 2013 - nature.com
… Colin JD Ross, Hagit Katzov-Eckert, Marie-Pierre Dubé, Beth Brooks, S Rod Rassekh,
Amina Barhdadi, Yassamin Feroz-Zada, Henk Visscher, Andrew MK Brown, Michael J …

[HTML][HTML] Re: Pharmacogenetic Testing Options Relevant to Psychiatry in Canada

M Dawes, H Katzov-Eckert… - … Canadian Journal of …, 2020 - journals.sagepub.com
Dear Editor Maruf et al. 1 have comprehensively reviewed pharmacogenetic testing options
relevant to psychiatry that are available in Canada. In the discussion, the authors point out …